Nuvectis Pharma, Inc. (NVCT)

CIK 1875558 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nuvectis Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 28, 2026EFFECT9999999995-26-002815
Aug 21, 20268-K0001104659-26-099712
Aug 21, 2026S-30001104659-26-099717
Aug 6, 2026SCHEDULE 13G0001213900-26-085988
Aug 5, 202640001104659-26-091279
Aug 4, 202610-Q0001104659-26-090109
Aug 4, 20268-K0001104659-26-090094
Jul 1, 202640001104659-26-079792
Jul 1, 202640001104659-26-079793
Jun 30, 20268-K0001104659-26-079360
Jun 30, 2026424B50001104659-26-079359
Jun 29, 20268-K0001104659-26-078823
Jun 29, 2026424B50001104659-26-078864
Jun 23, 20268-K0001104659-26-076624
Jun 12, 20268-K0001104659-26-073419
Jun 12, 202640001104659-26-073460
Jun 12, 202640001104659-26-073461
Jun 12, 202640001104659-26-073459
Jun 12, 202640001104659-26-073455
May 5, 202610-Q0001104659-26-055318
May 5, 20268-K0001104659-26-055264
Apr 27, 2026DEFA14A0001104659-26-049480
Apr 27, 2026DEF 14A0001104659-26-049476
Feb 20, 2026EFFECT9999999995-26-000644
Feb 13, 2026S-30001104659-26-015159